Abstract

There is limited data on postmortem oxycodone concentrations, consisting of three published reports with a total of 11 cases, many of which were polypharmacy cases. This report presents the results of a review of autopsy and coroner's reports from 10 counties for the years 2000 and 2001 to locate cases with oxycodone or hydrocodone exposure as a leading cause of death. Eighty-eight cases were located. Twenty-four deaths were attributed to oxycodone alone. Mean and median postmortem oxycodone blood concentrations were 1.23 mg/L and 0.43 mg/L, respectively. The range was 0.12 to 8.0 mg/L, with 13 cases (54%) ⩽0.5/L. Seventeen deaths were attributed to hydrocodone alone. Mean and median postmortem hydrocodone blood concentrations were 0.53 mg/L and 0.40 mg/L, respectively. The range was 0.12 to 1.6 mg/L, with 11 cases (65%) ⩽0.5/L. There were seven cases where the cause of death was attributed to the effects of a combination of hydrocodone and oxycodone. Mean oxycodone and hydrocodone blood concentrations were 0.34 mg/L and 0.14 mg/L, respectively. Forty cases involved polysubstance overdoses with significant involvement of other drugs and ethanol. Mean oxycodone and hydrocodone blood concentrations were 0.18 mg/L and 0.29 mg/L, respectively. The list of other substances involved was extensive but included ethanol, amitriptyline, methadone, codeine, propoxyphene, and acetaminophen. The findings of this study report oxycodone values associated with a fatality at blood concentrations lower than previously reported. This may represent enhanced information because of the larger sample group. Hydrocodone values associated with a fatality were similar to previously published values.

References

1.
Drummer
OH
,
Syrjanen
ML
,
Phelan
M
,
Cordner
SM
.
A study of deaths invoking oxycodone
.
J Forensic Sci
 0022-1198
1994
;
39
:
1069
75
.
2.
Fu
K
,
Konrad
RJ
,
Hardy
RW
,
Brissie
RM
,
Robinson
CA
.
An unusual multiple drug intoxication involving cilotapram
.
J Analytical Toxicol
 0146-4760
2000
;
24
:
648
50
.
3.
Baselt
RC
.
Oxycodone
. In:
Disposition of toxic drugs and chemicals in man
.
Baselt
RC
, editor.
Chemical Toxicology Institute
,
Foster City, CA
, 5th ed.
2000
;
644
5
.
4.
Baselt
RC
.
Hydrocodone
. In:
Disposition of toxic drugs and chemicals in man
.
Baselt
RC
, editors.
Chemical Toxicology Institute
,
Foster City CA
, 5th ed.
2000
;
422
3
.
5.
Vivian
D
.
Three deaths due to hydrocodone in a resin-complex cough mixture
.
Drug Itn Clin Pharm
 0012-6578
1979
;
13
:
445
6
.
6.
Park
JI
,
Nakamura
GR
,
Griesemer
,
Noguchi
TT
.
Hydromorphone detected in bile following hydrocodone ingestion
.
J Forensic Sci
 0022-1198
1982
;
27
:
223
4
.
7.
Morrow
PL
,
Faris
EC
.
Death associated with inadvertent hydrocodone overdose in a child with a respiratory tract infection
.
Amer J Forernsic Med Pathol
1987
;
8
:
60
3
.
8.
Dalpe-Scott
M
,
Degouffe
M
,
Garbutt
D
,
Drost
M
.
A comparison of drug concentrations in postmortem cardiac and peripheral blood in 320 cases
.
Can Soc Forensic Sci J
1995
;
28
:
113
21
.
9.
Takala
A
,
Kaasalainen
V
,
Seppala
T
,
Kalso
E
,
Olkkola
KT
.
Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone
.
Acta Anaesthesiol Scand
 0001-5172
1997
;
41
:
309
12
.
10.
Olkkola
KT
,
Hammunen
K
,
Seppala
T
,
Maunuksela
EL
.
Pharmacokinetics and ventilatory effects of intravenous oxycodone in postoperative children
.
Brit J Clin Pharmacol
1994
;
38
:
71
6
.
11.
Leow
KP
,
Smith
MT
,
Watt
JA
,
Williams
BE
,
Crammond
T
.
Compariative oxycodone pharmacokinetics in humans after intravenous, oral and rectal administration
.
Ther Drug Monit
 0163-4356
1992
;
14
:215.
12.
Leow
KP
,
Smith
MT
,
Williams
BE
,
Cramond
T
.
Single dose abd steadystate pharmacokinetics and pharmacodynaics of oxycodone in patients cancer
.
Clin Pharamcol Ther
 0009-9236
1992
;
52
:
487
95
.
13.
Kirvela
M
,
Lindgren
L
,
Seppala
T
,
Olkkola
KT
.
The pharmacokinetics of oxycodone in uremicpatients undergoing renal transplant
.
J Clin Anesth
 0952-8180
1996
;
8
:
13
8
.
14.
Banart
JW
,
Cadwell
WJ
.
Gas chromatographic determination of hydrocodone in serum
.
J Chromatogr
 0021-9673
1977
;
130
:
243
9
.
15.
Benziger
DP
,
Miotto
J
,
Grandy
RP
,
Thomas
GB
,
Swanton
RE
,
Fitzmartin
RD
.
A pharmacokinetic/pharmacodynamic study of controlled-release oxycodone
.
J Pain Symptom Manage
 0885-3924
1997
;
13
: 75–82.
This content is only available via PDF.
You do not currently have access to this content.